コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rolytic enzymes, are normally cleared by the mannose receptor).
2 (as determined by siRNA gene silencing of AM mannose receptors).
3 were rapidly cleared from the plasma by the mannose receptor.
4 in their low association with the macrophage mannose receptor.
5 complement receptors CR1, CR3, CR4, and the mannose receptor.
6 brin or the endocytic collagen receptor, the mannose receptor.
7 pendent mannose 6-phosphate receptor and the mannose receptor.
8 n-binding lectin, C-reactive protein and the mannose receptor.
9 parable with those found for cell-associated mannose receptor.
10 ycan by CD1b requires antigen uptake via the mannose receptor.
11 of trophic forms were not due to ligation of mannose receptor.
12 ocytic collagen receptors uPARAP/Endo180 and mannose receptor.
13 nt upregulated the M2 markers arginase 1 and mannose receptor.
14 Pneumocystis, including dectin-1, TLR2, and mannose receptor.
15 nocytosis or cellular entry via scavenger or mannose receptors.
16 upon the efficient uptake of mannoprotein by mannose receptors.
17 different receptors from the complement and mannose receptors.
18 ng their affinities for FimH and eight human mannose receptors.
22 sh-a2 tumors showed a reduced expression of mannose receptor-1 (CD206), interleukin-10, transforming
23 h early downregulation of surface receptors (mannose receptor-1 (MRC1) and C-type lectins), and subse
24 was characterized by elevated expression of mannose receptor-1, Arginase-1, interleukin-10 and trans
27 intensity detected by anti-human macrophage mannose receptor Abs, indicating that IL-13, like IL-4,
29 ocystis (Pc) organisms predominantly through mannose receptors, although the molecular mechanism medi
30 lecular pathway that links engagement of the mannose receptor, an important pattern recognition recep
32 ophages expressed C-lectins CD206/macrophage mannose receptor and CD209/DC-SIGN, as well as costimula
34 terminus of two human mAbs against the human mannose receptor and DEC-205, both internalizing molecul
37 ukin-10, and macrophage-specific transcripts mannose receptor and S100 calcium-binding protein A9, wh
40 f M. tuberculosis by engaging the macrophage mannose receptor and subsequently binds to intracellular
43 the serum as a consequence of binding to the mannose receptor and/or the asialoglycoprotein receptor
44 tyl-<cmd SC>d<cmd /SC> -glucosamine) through mannose receptors and produce IL-12, IL-18, and TNF-alph
45 CD68 (macrophage marker), M2 markers (CD206 (mannose receptor) and CD163 (scavenger receptor)), secre
47 ocytosis, reduced expression of MARCO and of mannose receptor, and absent expression of scavenger rec
49 blocked by saccharides or Abs reactive with mannose receptor, and is dependent upon the state of mat
51 ecognition receptors tested (CD11b/CD18, the mannose receptor, and the N-formyl-methionyl-leucyl-phen
53 ion receptors for fungi include dectin-1 and mannose receptor, and these mediate phagocytosis, as wel
55 ently than N or P by mechanisms depending on mannose receptor- and dendritic cell-specific intercellu
56 monstrate that FDM restricts binding of anti-mannose receptor antibody to macrophages by approximatel
57 ges through glucose transporters and because mannose receptors are expressed on a subset of the macro
58 ll receptor, integrin alphaM, and macrophage mannose receptor, are engaged in N-glycan ligand recogni
62 dhesion molecule-3-grabbing nonintegrin, and mannose receptor as well as the inflammatory markers CD6
63 ctor functions, the present study identifies mannose receptors as pattern recognition receptors capab
64 alleles) and mediated predominantly through mannose receptors (as determined by siRNA gene silencing
66 ly by complement and partially by macrophage mannose receptors, as demonstrated by in vitro assays.
67 erfere with the arrival of newly synthesized mannose receptors at the cell surface, also attenuated m
68 lly resulting in decreased levels of surface mannose receptor available for Ag or pathogen capture.
70 e studies was to characterize the macrophage mannose receptor binding and pharmacological properties
71 taining the cysteine-rich (CR) domain of the mannose receptor, binds to marginal zone metallophilic m
72 lecule-3 grabbing non-integrin (DC-SIGN) and mannose receptor, bound to FL surface immunoglobulin (sI
73 at sMR was produced by cleavage of an intact mannose receptor by a matrix metalloprotease or ADAM met
74 ides corti, we have investigated the role of mannose receptor C type 1 (MRC1), a CLR which recognizes
75 th MaR1 showed a significant upregulation of mannose receptor C, type 1 mRNA expression, an M2 macrop
76 inity for both the insulin receptor (IR) and mannose receptor C-type 1 (MR), which functions to clear
77 ferator-activated receptor gamma (PPARG) and mannose receptor C-type 1 (MRC1), suggesting that PRMT1
80 egfp)(y251) transgenic zebrafish that uses a mannose receptor, C type 1 (mrc1a) promoter to drive str
81 human urine: cadherin 11 (CDH11), macrophage mannose receptor C1 (MRC1), and phospholipid transfer pr
82 Fc chimeras revealed that LRP, DC-SIGN, and mannose receptor can bind to FVIII; however, we did not
84 eath ligand-1 (PD-L1), Mac-2, and macrophage mannose receptor (CD206) and producing Klf4, Il10, Retnl
85 s demonstrated a significant increase in the mannose receptor (CD206) and the CD14(+)/CD206(+) double
86 mannoprotein was captured by the macrophage mannose receptor (CD206), these data suggest that multip
88 pressing the multi-ligand endocytic receptor mannose receptor (CD206/MRC1) contribute to tumor immuno
89 rotein 10, and IRG1 in macrophages that lack mannose receptor, complement receptors 3 and 4, type A s
90 ns 4-7 and a full-length soluble form of the mannose receptor containing all domains external to the
93 ulating CEA was preferentially taken up in a mannose receptor-dependent manner and cross-presented by
95 terns that stimulate TLR2, dectin-1, and the mannose receptor, differentially activate NF-kappaB and
96 ting of soluble exogenous tumor Ag to the DC mannose receptor directly contributes to the generation
100 macrophages from healthy individuals reduced mannose receptor endocytosis to 53.2% (P < 0.05) and P.
103 as a model human disease state of reduced AM mannose receptor expression and function) inhibits Pneum
104 HIV infection of AMs (as a model for reduced mannose receptor expression and function) was associated
105 e synthase staining in rodent tissue, and by mannose receptor expression in human breast tissue.
107 mune recognition by the structurally related mannose receptor family and comparison of diverse method
108 ipase A2 receptor (PLA2R) is a member of the mannose receptor family found in podocytes in human kidn
109 f the mammalian phospholipase A2 receptor, a mannose receptor family member, rather than an FcRn or M
111 nchymally expressed member of the macrophage mannose receptor family of endocytic receptors, is a key
112 e identification of three new members of the mannose receptor family, additional work on defining the
115 competed with the C-type lectins DC-SIGN and mannose receptor for ligand binding and inhibited the bi
117 n, a preparation that antagonizes macrophage mannose receptors, had minimal effect on TNF-alpha relea
119 Binding of organisms to beta-glucan and mannose receptors has been shown to stimulate phagocytos
120 ion cloning strategy, the cDNA for the human mannose receptor (hMR) was found to be essential for CD4
121 t of manY corresponds to IIPMan, manZ to the mannose receptor IIBMan, and manX and manW to the single
122 phages, messenger RNA expression of FR-beta, mannose receptor, IL-10, and matrix metalloproteinase-9
123 quirements for sugar binding, a role for the mannose receptor in antigen presentation of lipoglycan a
129 eliminated uptake by mannose 6-phosphate and mannose receptors in cultured cells and dramatically slo
131 s have reduced functions associated with the mannose receptor, including impaired Pneumocystis carini
133 locked by the addition of mannan, suggesting mannose receptor involvement in the DC-Coccidioides inte
134 of lipoglycan antigens and evidence that the mannose receptor is associated with a signal transductio
137 by mannose-capped lipoarabinomannan and the mannose receptor is independent of TLR2 and NF-kappaB ac
138 lso found that the surface expression of the mannose receptor is not downregulated during P. carinii
139 icate that the well-characterised macrophage mannose receptor is not essential to host defence agains
140 myeloid promoters, transcription of the rat mannose receptor is regulated by binding of PU.1 and a u
143 sceptible to P. carinii by CD4(+) depletion, mannose receptor knockout mice (MR-KO) had pathogen load
145 4GGnM-R is closely related to the macrophage mannose receptor (Man-R) both antigenically and structur
146 e asialoglycoprotein receptor (ASGR) and the mannose receptor (ManR) are expressed in the liver by pa
148 other alternative state (M2)-specific genes (Mannose receptor, MAO-A, and CD36) and therefore conclud
150 r findings suggest that while the macrophage mannose receptor may be important in the recognition of
151 lungs, and that impaired alveolar macrophage mannose receptor-mediated binding and phagocytosis of P.
153 ere highly efficient at Ag capture, via both mannose receptor-mediated endocytosis and macropinocytos
154 f-assembled nanocomplexes (SSANs) capable of mannose receptor-mediated endocytosis and permeable to c
155 luorescein isothiocyanate (FITC)-albumin and mannose receptor-mediated endocytosis of FITC-dextran by
156 IL-10 (type 2) cytokines on fluid phase and mannose receptor-mediated endocytosis were assessed by h
159 /mL), rapamycin impairs macropinocytosis and mannose receptor-mediated endocytosis; (2) the effects a
162 se data provide a molecular mechanism for AM mannose receptor-mediated phagocytosis of unopsonized Pc
163 Taken together, our results indicate that mannose receptor-mediated phagocytosis, but not the rece
165 d IL-13 enhanced fluid phase pinocytosis and mannose receptor-mediated uptake by activation of phosph
167 d Nanobodies directed against the macrophage mannose receptor (MMR) is a useful tool for monitoring a
168 products, whereas the homologous macrophage mannose receptor (MMR), as expected, is found in more pe
169 ster ovary cells expressing human macrophage mannose receptor (MMR), we determined that MP is a MMR l
170 sdAbs) specifically targeting the macrophage mannose receptor (MMR), which has been identified as an
173 nnosylated LAM (ManLAM) binds the macrophage mannose receptor (MMRc), although the ability of the MMR
175 of serum opsonins, competitive inhibition of mannose receptor (MR) activity on MDM with mannan decrea
182 ound and internalized via its glycans by the mannose receptor (MR) and subsequently impairs protein s
186 ptor with collagenous structure (MARCO), and mannose receptor (MR) have been identified as nonopsonic
187 ain, by human macrophages is mediated by the mannose receptor (MR) in addition to complement receptor
189 We investigated how innate sensing by the mannose receptor (MR) influences the development of anti
194 ficantly decreased the surface expression of mannose receptor (MR) on adherent peripheral blood monon
198 fied antibodies redirected bacteria from the mannose receptor (MR) to the complement receptor CR3, th
200 -derived macrophages (BMDMs) in vitro and by mannose receptor (MR)(hi) dermal macrophages in vivo com
202 art, to increased activity of the macrophage mannose receptor (MR), a pattern recognition receptor fo
204 t of a carbohydrate receptor, the macrophage mannose receptor (MR), and its role in supporting HIV-1
205 MP is its capacity to bind to the conserved mannose receptor (MR), CD206, on dendritic cells (DCs).
206 one marrow-derived macrophages isolated from mannose receptor (MR), complement receptor 3 (CR3), MyD8
207 ular, C-type lectin receptors, including the mannose receptor (MR), facilitate APC-mediated adsorptiv
211 osclerotic plaque areas enriched in CD68 and mannose receptor (MR)-positive (CD68(+)MR(+)) alternativ
216 proteins: macrophage receptors, such as the mannose receptor (MR, CD206), dendritic cell-specific IC
218 ionally, competitive blockade of multilectin mannose receptors (MR) on APCs diminished MP-dependent s
219 nzyme with exposed mannosyl residues targets mannose receptors (MR) on macrophages, ERT targets prima
220 ss several cell surface receptors (e.g., the mannose receptor, MR) that may serve as drug delivery ce
222 Genetic ablation of the collagen receptors mannose receptor (Mrc1) and urokinase plasminogen activa
223 on C-type-lectin receptors (CLRs), including mannose receptor (MRC1; CD206), have been suggested to f
224 interfering RNA-mediated gene suppression of mannose receptor mRNA and protein is associated with com
228 increases uptake of soluble IgG mediated by mannose receptor on macrophages and dendritic cells.
230 in pathogenesis, either by interaction with mannose receptors on host cells, or as targets or modula
232 l interfering RNA-mediated knockdown of LRP, mannose receptor, or DC-SIGN expression in monocyte-deri
233 arbohydrate remodeling improved targeting to mannose receptors over native enzyme by two orders of ma
234 crophages, although a higher proportion were mannose receptor positive, a characteristic of different
235 tion of CCL18 in CD68(+)/CD163(+)/macrophage mannose receptor-positive M2 macrophages and tryptase-po
236 s exposed to red cells showed an increase in mannose receptor-positive macrophages only when these ce
237 an alternative phenotype being both CD68 and mannose receptor-positive, expressing carbonic anhydrase
238 /reperfusion injury, whereas arginase 1- and mannose receptor-positive, noninflammatory (M2) macropha
239 sistent with a mechanism whereby Tat reduces mannose receptor promoter activity by interfering with t
240 nstruct of USF resulted in a 50% decrease in mannose receptor promoter activity, further establishing
242 tion factors Sp1, PU.1, and USF bound to the mannose receptor promoter, but only PU.1 and USF contrib
243 line U937 with a Tat expression vector and a mannose receptor promoter-luciferase reporter construct
248 t defence: phagocytic receptors, such as the mannose receptor, signal particle internalization, and t
252 polysaccharide structure and binding to the mannose receptor, suggesting that polysaccharide conform
253 strated up to an 80% (P < 0.05) reduction in mannose receptor surface expression and endocytosis.
255 n vivo experiments in mice revealed that the mannose receptor system on macrophages also participates
256 an BDCA1+ and monocyte-derived DCs, CD40 and mannose receptor targeted antibody conjugates to early e
257 to macrophages by approximately 35% and that mannose receptor targeting may provide an additional ave
258 have generated a human mAb (B11) against the mannose receptor that is rapidly internalized by DCs thr
259 ted number of phagocytic receptors, like the mannose receptor, that recognize conserved motifs on pat
260 expose terminal mannose residues and target mannose receptors, the uptake of this modified enzyme fo
262 that binding of type 1 fimbriae (pili) to d-mannose receptors triggers a cross talk that leads to do
263 n mannose-binding protein and the macrophage mannose receptor, two mammalian C-type lectins, bind to
264 ulated in culture, whereas macrophage genes, mannose receptor type-1, Cd68, serum amyloid-A3, chemoki
270 that exploits endocytosis via the macrophage mannose receptor, was constructed and complexed to expre
271 in inflammatory zone 1, Ym1, and macrophage mannose receptor were observed in the lungs of mice infe
274 on of strongly adherent bacteria by blocking mannose receptors with a soluble inhibitor actually incr
275 y for uptake of exogenous LPLA(2) is via the mannose receptor, with subsequent translocation into aci
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。